Fluorescein angiography and adverse drug reactions revisited: The Lions Eye experience

Clinical and Experimental Ophthalmology

Volumn 34, Issue 1, 2006, Pages 33-38

  Kwan, Anthony S L ^a   Barry, Chris ^a   McAllister, Ian L ^a   Constable, Ian ^a  

^a LIONS EYE INSTITUTE   (Australia)

Author keywords

Adverse drug reaction; Anaphylactoid reaction; Anaphylaxis; Fluorescein angiography

Indexed keywords

FLUORESCEIN SODIUM;

ANAPHYLAXIS; ARTICLE; CHORIORETINOPATHY; DATA BASE; DESENSITIZATION; DIZZINESS; DRUG FATALITY; DRUG SAFETY; EDEMA; FEMALE; FLUORESCENCE ANGIOGRAPHY; HEART INFARCTION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NAUSEA; OPTICAL COHERENCE TOMOGRAPHY; PAIN; PATHOGENESIS; PROPHYLAXIS; REGISTER; RETROSPECTIVE STUDY; SEIZURE; STATISTICAL SIGNIFICANCE; SYNCOPE; URTICARIA; VOMITING;

ADVERSE DRUG REACTION REPORTING SYSTEMS; ANAPHYLAXIS; AUSTRALIA; DIZZINESS; DRUG HYPERSENSITIVITY; FEMALE; FLUORESCEIN; FLUORESCEIN ANGIOGRAPHY; HEALTH SURVEYS; HUMANS; INCIDENCE; MALE; MYOCARDIAL INFARCTION; NAUSEA; RETROSPECTIVE STUDIES; URTICARIA; VOMITING;

EID: 33644926712     PISSN: 14426404     EISSN: 14429071     Source Type: Journal    
DOI: 10.1111/j.1442-9071.2006.01136.x     Document Type: Article

References (50)

1. Novtny HR, Alvis DL. A method of photographing fluorescence in circulating blood in the human retina. Circulation 196; 24: 28-86.
2. Yannuzzi LA, Rohrer KT, Tindel LJ et al. Fluorescein angiography complication survey. Ophthalmology 1986; 93: 611-17.
3. Kwiterovich KA, Maguire MG, Murphy RP et al. Frequency of adverse systemic reactions after fluorescein angiography. Results of a prospective study. Ophthalmology 1991; 98: 1139-42.
4. McLauchlan R, Waterman H, Waterman C, Hillier V, Dodd C. Ethnic variation in fluorescein angiography induced nausea and vomiting. Eye 2001; 15: 159-162
5. Fraunfelder FW. Ocular adverse drug reactions. Expert Opin Drug Saf 2003; 2: 411-20.
6. Berlman IB. Handbook of Fluorescence Spectra of Aromatic Molecules, 2nd edn. New York: Academic Press, 1971.
7. The Centers for Medicare and Medicaid Services, USA. Top 200 Level I Current Procedural Terminology Codes (FFA procedure code 92235) 2002. Available from: http://www.cms.hhs.gov/statistics/feeforservice/ top200L1cptbyservices02.asp
8. Butner RW, McPherson AR. Adverse reactions in intravenous fluorescein angiography. Ann Ophthalmol 1983; 15: 1084-6.
9. Jennings BJ, Mathews DE. Adverse reactions during retinal fluorescein angiography. J Am Optom Assoc 1994; 65: 465-471.
10. Karhunen U, Raitta C, Kala R. Adverse reactions to fluorescein angiography. Acta Ophthalmol (Copenh) 1986; 64: 282-6.
11. Halperin, LS., Olk, RJ., Soubrane, G., Coscas, G. Safety of fluorescein angiography during pregnancy. Am J Ophthalmol. 1990; 109: 563-566.
12. Acheson R, Serjeant G. Painful crises in sickle cell disease after fluorescein angiography. Lancet 1985; 1: 1222.
13. Bloom JN, Herman DC, Elin RJ et al. Intravenous fluorescein interference with clinical laboratory tests. Am J Ophthalmol 1989; 108: 375-9.
14. Munizza M, Kavitsky D, Schainker BA, Poyser A, Peek C, Nance S. Hemolytic anemia associated with injection of fluorescein. Transfusion 1993; 33: 689-92.
15. Edwards IR, Aronson JK. Adverse drug reactions: Definitions, diagnosis, and management. Lancet 2000; 356: 1255-9.
16. Pacurariu RI. Low incidence of side effects following intravenous fluorescein angiography. Ann Ophthalmol 1982; 14: 32-6.
17. Elman MJ, Fine SL, Sorenson J et al. Skin necrosis following fluorescein extravasation. A survey of the Macula Society. Retina 1987; 7: 89-93.
18. Buchanan RT, Levine NS. Blood pressure drop as a result of fluorescein injection. Plast Reconstr Surg 1982; 70: 363-8.
19. Baraka A, Moghrabi R, Sibai AN, Haidar J. Cardiovascular collapse following intravenous fluorescein sodium. Middle East J Anesthesiol 1986; 8: 437-40.
20. Gombos GM, Lieberman RM. Seizures associated with fluorescein angiography. Ann Ophthalmol 1989; 21: 89-90.
21. Hess JB, Pacurariu RI. Acute pulmonary edema following intravenous fluorescein angiography. Am J Ophthalmol 1976; 82: 567-70.
22. American Academy of Allergy, Asthma and Immunology, American College of Allergy, Asthma and Immunology, and the Joint Council of Allergy, Asthma and Immunology. The diagnosis and management of anaphylaxis. Joint task force on practice parameters. J Allergy Clin Immunol 1998; 101: S465-528.
23. Valvano MN, Martin TP. Periorbital urticaria and topical fluorescein. Am J Emerg Med 1998; 16: 525-6.
24. Hara T, Inami M, Hara T. Efficacy and safety of fluorescein angiography with orally administered sodium fluorescein. Am J Ophthalmol 1998; 126: 560-4.
25. Arroyave CM, Wolbers R, Ellis PP. Plasma complement and histamine changes after intravenous administration of sodium fluorescein. Am J Ophthalmol 1979; 87: 474-9.
26. Butrus SI, Negvesky GJ, Rivera-Velazques PM, Schwartz LB. Serum tryptase: An indicator of anaphylaxis following fluorescein angiography. Graefes Arch Clin Exp Ophthalmol 1999; 237: 433-4.
27. Schwartz LB, Metcalfe DD, Miller JS, Earl H, Sullivan T. Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis. N Engl J Med 1987; 316: 1622-6.
28. Heffner JE. Reactions to fluorescein. JAMA 1980; 243: 2029-30.
29. Anderson JA. Allergic reactions to drugs and biological agents. JAMA 1992; 268: 2844-47.
30. Nucera E, Schiavino D, Merendino E et al. Successful fluorescein desensitization. Allergy 2003; 58: 458.
31. Chazan BI, Balodimos MC, Koncz L. Untoward effects of fluorescein retinal angiography in diabetic patients. Ann Ophthalmol 1971; 3: 42.
32. Marcus DF, Bovino JA, Williams D. Adverse reactions during intravenous fluorescein angiography. Arch Ophthalmol 1984; 102: 825.
33. Zografos L. [International survey on the incidence of severe or fatal complications which may occur during fluorescein angiography.] J Fr Ophthalmol 1983; 6: 495-506.
34. Cashman JD, McCredie J, Henry DA. Intravenous contrast media: Use and associated mortality. Med J Aust 1991; 155: 618-23.
35. Caro JJ, Trindade E, McGregor M. The risks of death and of severe nonfatal reactions with high- vs low-osmolality contrast media: A meta-analysis. Am J Roentgenol 1991; 156: 825-32.
36. Katayama H, Yamaguchi K, Kozuka T, Takashima T, Seez P, Matsuura K. Adverse reactions to ionic and nonionic contrast media. A report from the Japanese Committee on the Safety of Contrast Media. Radiology 1990; 175: 621-8.
37. Greenberger PA. Contrast media reactions. J Allergy Clin Immunol 1984; 74: 600-5.
38. Cochran ST, Bomyea K, Sayre JW. Trends in adverse events after IV administration of contrast media. Am J Roentgenol 2001; 176: 1385-8.
39. Justice J Jr, Paton D, Beyrer CR, Seddon GG. Clinical comparison of 10 percent and 25 percent intravenous sodium fluorescein solutions. Arch Ophthalmol 1977; 95: 2015-16.
40. Lee LR, Hainsworth DP, Hamm CW, Madsen RW. Temperature effect on nausea during fluorescein angiography. Ophthalmology 2001; 108: 1193-5.
41. Greene GS, Bell LW, Hitching RA, Spaeth GL. Adverse reaction to intravenous fluorescein: Evidence for sex difference. Ann Ophthalmol 1976; 8: 533-6.
42. Saine PJ, Tyler ME. Ophthalmic Photography: Retinal Photography, Angiography, and Electronic Imaging, 2nd edn. London: Elsevier Science, 2002.
43. Yannuzzi LA, Justice J Jr, Baldwin HA. Effective differences in the formulation of intravenous fluorescein and related side effects. Am J Ophthalmol 1974; 78: 217-21.
44. Jacob JS, Rosen ES, Young E. Report on the presence of a toxic substance, dimethyl formamide, in sodium fluorescein used for fluorescein angiography. Br J Ophthalmol 1982; 66: 567-8.
45. Chappell AJ, Della NG. Back pain reactions to intravenous sodium fluorescein. J Ophthal Photog 2001; 23: 54-9.
46. Rohr AS, Pappano JE Jr. Prophylaxis against fluorescein-induced anaphylactoid reactions J Allergy Clin Immunol 1992; 90: 407-8.
47. Garcia CR, Rivero ME, Bartsch DU et al. Oral fluorescein angiography with the confocal scanning laser ophthalmoscope. Ophthalmology 1999; 106: 1114-18.
48. Sullivan TJ. Penicillin allergy - diagnosis and management. Geriatrics 1983; 38: 63-6.
49. Puliafito CA, Hee MR, Lin CP et al. Imaging of macular diseases with optical coherence tomography. Ophthalmology 1995; 102: 217-29.
50. Spring DB, Akin JR, Margulis AR. Informed consent for intravenous contrast-enhanced radiography: A national survey of practice and opinion. Radiology 1984; 152: 609-13.